Oliver Lagore Vanvalin Investment Group Milestone Pharmaceuticals Inc. Transaction History
Oliver Lagore Vanvalin Investment Group
- $263 Million
- Q2 2025
A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 100 shares of MIST stock, worth $166. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$166
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding MIST
# of Institutions
55Shares Held
19MCall Options Held
160KPut Options Held
34.8K-
Black Rock Inc. New York, NY4.97MShares$8.25 Million0.0% of portfolio
-
Simplify Asset Management Inc. New York, NY2.83MShares$4.7 Million0.32% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$4.16 Million0.07% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.79MShares$2.97 Million4.22% of portfolio
-
Alta Fundamental Advisers LLC New York, NY1.4MShares$2.32 Million1.22% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $49.8M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...